Office of the United States Trade Representative March 25, 2020 – Federal Register Recent Federal Regulation Documents

Request for Comments on Additional Modifications to the 301 Action To Address COVID-19: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation
Document Number: 2020-06285
Type: Notice
Date: 2020-03-25
Agency: Office of the United States Trade Representative
In prior notices, the U.S. Trade Representative has modified the action in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by removing additional duties from medical-care products needed to address the COVID-19 outbreak. In light of ongoing developments, the Office of the U.S. Trade Representative (USTR) is requesting public comments on possible further modifications to remove duties from additional medical-care products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.